COMMUNIQUÉS West-GlobeNewswire

Press release: Sanofi successfully prices EUR 1.5 billion of bond issue
05/03/2025
Sanofi successfully prices EUR 1.5 billion of bond issue Paris, March 5, 2025. Sanofi announces that it has successfully priced its offering of EUR 1.5 billion of notes across 2 tranches: €850 million floating rate [...]
Communiqué de presse : Sanofi place 1,5 milliard d’euros d’emprunts obligataires
05/03/2025
Sanofi place 1,5 milliard d’euros d’emprunts obligataires Paris, 5 mars 2024. Sanofi annonce avoir placé avec succès une émission obligataire en 2 tranches (les « obligations ») pour un montant de 1,5 milliard d’euros [...]
VALNEVA Declaration of shares and voting rights: February 28, 2025
05/03/2025
VALNEVA Declaration of shares and voting rights February 28, 2025 __________________________________________________________________________________________ Company name: VALNEVA Registered office: 6 rue Alain Bombard, [...]
VALNEVA Déclaration d’actions et de droits de vote : 28 février 2025
05/03/2025
VALNEVA Déclaration d’actions et de droits de vote 28 février 2025 __________________________________________________________________________________________ Dénomination sociale : VALNEVA Adresse du siège social : 6 [...]
BioNexus Gene Lab Corp. Announces Board Approval of Ethereum Treasury Strategy and Release of Strategic Whitepaper
05/03/2025
KUALA LUMPUR, Malaysia, March 06, 2025 (GLOBE NEWSWIRE) -- BioNexus Gene Lab Corp. (NASDAQ: BGLC), a technology company dedicated to innovation in technology and healthcare, is pleased to announce that its Board of [...]
Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)
05/03/2025
ORION CORPORATION STOCK EXCHANGE RELEASE / MAJOR SHAREHOLDER ANNOUNCEMENTS 5 March 2025 at 17.00 EET Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.) Orion [...]
Longeveron® to Present at the 37th Annual Roth Conference
05/03/2025
MIAMI, March 05, 2025 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage regenerative medicine biotechnology company developing cellular therapies for life-threatening and chronic aging-related [...]
Pow.Bio Unveils State-of-the-Art Facility in Alameda, Expanding Biomanufacturing Capabilities to Support Demand for Continuous Fermentation
05/03/2025
ALAMEDA, Calif., March 05, 2025 (GLOBE NEWSWIRE) -- Pow.Bio , a leader in innovative biomanufacturing solutions, is pleased to announce the opening of its new cutting-edge facility in Alameda, California. The new 25,000 [...]
NeuroOne® to Present at the Oppenheimer 35th Annual Healthcare MedTech & Services Conference
05/03/2025
EDEN PRAIRIE, Minn., March 05, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and [...]
Parexel Announces Updates to Board of Directors
05/03/2025
Jeff Bernstein, Partner, Private Equity, Goldman Sachs Asset Management, and Co-Head, Goldman Sachs Healthcare Private Equity Investing, joins as new Director. Mr. Bernstein succeeds Michael Bruun in the Goldman Sachs [...]
Tenax Therapeutics Announces $25 Million Private Placement
05/03/2025
CHAPEL HILL, N.C., March 05, 2025 (GLOBE NEWSWIRE) -- Tenax Therapeutics, Inc. (Nasdaq: TENX) (the “Company” or “Tenax Therapeutics”), a Phase 3, development-stage pharmaceutical company using clinical insights to [...]
Global Mental Health Leaders Convene in Canada to Address the Root Causes of the Youth Mental Health Crisis
05/03/2025
Canadian charity Jack.org, the International Association for Youth Mental Health, and partners will lead Vancouver conference on March 18th-21st to develop a blueprint for global action on youth mental health TORONTO, [...]
Des leaders mondiaux en santé mentale se rassemblent au Canada pour aborder les causes structurelles de la crise de la santé mentale des jeunes
05/03/2025
L’organisme caritatif canadien Jack.org, l’International Association for Youth Mental Health (IAYMH) et leurs partenaires organiseront une conférence à Vancouver du 18 au 21 mars pour élaborer un plan d’action global en [...]
Tenax Therapeutics Expands Phase 3 LEVEL Program, Advancing Two TNX-103 (Oral Levosimendan) Registrational Studies for the Treatment of PH-HFpEF
05/03/2025
Amendment to Enlarge Phase 3 LEVEL Study, Increasing Statistical Powering, Accepted by FDA, Expected to be Fully Enrolled Around Year End 2025 Agreement by FDA to Initiate Second Global Phase 3 Study, LEVEL-2, with [...]
Serotonin Centers Announces Addition of NAD+ Therapy to Anti-Aging Medical Offerings
05/03/2025
All U.S. Locations Now Offer Revolutionary NAD+ Therapy to Enhance Cellular Regeneration, Boost Performance, and Redefine Anti-Aging Solutions ORLANDO, Fla., March 05, 2025 (GLOBE NEWSWIRE) -- Serotonin Anti-Aging [...]
Sofwave Medical Reports Fourth Quarter and Full Year 2024 Financial Results and Business Highlights
05/03/2025
– Fourth quarter revenue of $18.3M, +20% year-over-year growth; IFRS gross margin of 77.0% – Full fiscal 2024 revenue of $59.7M, +19% year-over-year growth; IFRS gross margin of 76.0% – Full fiscal 2024 pulse recurring [...]
Daxor Corporation Reports Increase in NAV to $7.25 Per Share and 116.5 Percent Increase in Unaudited Revenue of Operating Division for the Year Ended December 31, 2024
04/03/2025
Strong Start to 2025 with Unaudited Revenue Increases Leading to Cash Flow Positive Operating Company Results Oak Ridge, TN, March 04, 2025 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood [...]
LUKE and the American Association of Christian Counselors Announce Partnership to Expand Human Flourishing Support for Military, Veterans, First Responders, and Their Families
04/03/2025
ROCKLEDGE, Fla., March 04, 2025 (GLOBE NEWSWIRE) -- LUKE Holdings, Inc. (“LUKE”), a trusted leader in healthcare staffing for the U.S. Government, has joined forces with the American Association of Christian Counselors [...]
Supernus to Participate in Two Upcoming Investor Conferences
04/03/2025
ROCKVILLE, Md., March 04, 2025 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous [...]

Pages